- Homepage
- Wir über uns
- BEHANDLUNGEN
- BEHANDLUNGEN
- ZIEL
- KRANKENHÄUSER
- KONTAKT
Located within the boundaries of Boğazkale District, southwest of Çorum, Hattusas had served as the capital of the Hittite Empire for 450 years, between 1650-1200 BC, extending over a 180-hectare rough and rocky terrain. During the Hittite Empire, this magnificent city used to be surrounded by 6 kilometers long city walls with high towers at certain intervals. The monumental gateways through these walls made entries and exits possible at old times. Such gates as Aslanlı Kapı (which has lion statues on it- so to say, the Lion's Gate), the Sphinx Gate and the Royal Gate are decorated with reliefs indicating a high talent and taste of delicate stonemasonry. At the farthest southern point of the city, the walls passes over a piled earth level considered to be the city’s crown. Just beneath the Sphinx Gate standing at the central point here, a potern tunnel of 71 meters was formed. The restoration works carried out there up to now with an original system has transformed the ancient capital city, which still stands up against the pressure of time, into an open air museum.
The Hittite Empire ruled across a wide geography, dominating lots of people of different origins. With this attempt seen as a political preference, the gods of different communities were brought together under an official pantheon. In so doing, different communities under the dominance of Hittites were made to live together under a central power. Together with their unique cultural elements, the Indo-European Hittites had adopted many other cultural details of various cultures they met and found acceptable to their own while defining themselves as the Nation of One Thousand Gods. Hattusas was not only the administrative capital but also the religious centre of the whole Empire. As one of the leading 31 temples of Hittites, the Great Temple (Büyük Mabet) was the place wherein they worshipped two gods they considered as the most powerful- Storm God of Hatti and the Sun Goddess of the Arinna City. As the most impressive centre of divinity, Yazılıkaya Open Air Shrine was especially used for the new year celebrations during spring months. The leading gods and goddesses inscribed, in series, onto rocks best reflect the religious diversity of the Hittites. Since the lands of Anatolia being the passageways between the East and the West were under the control of Hittites, the mythological stories created by the Sumerians in Mesopotamia were first carried to Hittities from Hurrians. And then, Hittites took them further and transported them to the Ancient Greek Civilization.
Hattusas was inscribed to the World Heritage List of UNESCO in 1986. Some of the reasons why Hatussas was added to the World Heritage List of UNESCO are as follows:
Furthermore, the cuneiform tablet archives of Hattusas that symbolize the oldest recorded Indo-European language became involved in UNESCO's Memory of World Register in 2001. And so, Hattusas still enjoys the privilege to be the first, and for now, the last asset placed in both cruical lists of UNESCO.
Hattusas is situated in Boğazkale District of Çorum Province. It is located 87 kilometer to the southwest of Çorum. It is 220 km from Ankara and 215 km from Ankara Esenboğa Airport whereas the distance from Merzifon Airport is 150 km.
This Consent and Information Document (“Information Document”) regulates terms and conditions for use of the data notified by Users of services (“Patients”) and/or gained from Patients during delivery of Oba Tourism Organization Adversiment and Publishing Limited Company (“Medithrace”) with headquarter at Ertuğrul Mah. Orduevi Cad. No 2 Süleymanpaşa - Tekirdağ pursuant to Personal Data Protection Law (Nr. 6698) activities performed to deliver services, including “Free-of-charge Second Opinion and Health Counseling” (“Services”) at contract partner hospitals (“Hospitals”) with details written below.
How is your medical history and health information obtained?
Your personal health details are derived from “your medical reports, details about medications you take, epicrisis, imaging studies, imaging reports and pathology reports” that you submit us and they are shared with or disclosed to partner hospitals in Turkey and their relevant personnel in order to create your treatment plan.
Which data is processed?
This article lists the data that is regarded as personal data in Personal Data Protection Law (Nr. 6698) and processed by Medithrace for the services delivered to patients. Unless otherwise is stated, “Personal Data” and “Data with Specific Quality (Sensitive”) shall have following meanings pursuant to terms and conditions of this Information Document.
Hospital collects following data that are notified by Patients.
● Identity - Address Details: Name surname, identity number, gender, date of birth, business or personal e-mail, phone number, home address or business address that are written on relevant forms,
● Health Evaluation Details: Your medical history, medical reports, details of medications you take, epicrisis, imaging studies, imaging reports and pathology reports.
● Extra data: Other health and/or personal information that is required for service delivery and not covered in above written data classes.
Pursuant to Articles 3 and 7 of Personal Data Protection Law (Nr. 6698) and regulations to be issued by the Committee, personal data or sensitive data shall not cover the data that is anonymized by deleting your identity details in an irreversible manner and terms and conditions of this Information Document, hereby, shall not apply to such data.
Why do we use your data?
Your data is shared with or disclosed to physicians, healthcare staff and other relevant hospital personnel to help our firm provide you with “free-of-charge second opinion” service that is rendered in relation with your probable treatment. Thus, they are used to have contract hospitals create a complete treatment plan and submit estimated cost.
Hospitals may process the personal data notified by the Patient and the new data derived by the Hospital from the personal data in order to help the Patient use the Services, deliver the Services, fulfill the intended use of the personal data specified in this Information Document, fulfill the liabilities arising out of the content of Services and meet any and all legal obligations.
In addition, the Hospital may process the personal data and disclose them to third parties without any need to consent of the Patient pursuant to Articles 5, 6 and 8 of Personal Data Protection Law (Nr. 6698) and/or in the presence of exemptions in the relevant legislation.
Allowed Disclosures
Medithrace shall be entitled to disclose the personal data notified by the Patient and the new data derived by the hospital from the personal data in order to render the Services, improve the patient experience, improve Services and achieve any one of the goals specified under the section “Why do we use your data?” of this Information Policy.
Your personal, clinical and genetic data collected pursuant to this Information Document, hereby, shall be processed in line with the provisions written in this document and the provisions and security measures dictated by relevant legislation of the country, where the data is stored and/or processed.
Your Right to Access Your Data and Your Correction Requests
The patient shall have the following rights by applying to Medithrace;
● Learning if the personal data is processed or how it is processed,
● Requesting relevant information, if personal data is processed,
● Learning the intent of processing personal data and whether they are used in line with the intention,
● Learning local and international third parties who are shared the personal data,
● Requesting correction, if personal data is processes incompletely or incorrectly,
● Requesting correction, deletion or disposal of the personal data in line with the provisions set by relevant legislation; requesting notification of the correction, deletion or disposal to third parties that are transferred the personal data,
● Raising an objection to a negative outcome arising out of analyzing the data exclusively with automated systems,
● Requesting compensation of loss and damage that arises out of illegal processing of personal data.
The patient may post the request in writing to Ertuğrul Mah. Orduevi Cad. No: 2 Süleymanpaşa - Tekirdağ or e-mail the request letter to info@medithrace.com. Medithrace shall issue and transfer the positive or negative response in writing or electronically pursuant to the above mentioned requests, provided the grounds of negative response are notified. The Patient undertakes that the details subject to this Information Policy are complete, correct and up-to-date and that they will be immediately updated in case of any change Medithrace shall assume no responsibility, if up-to-date information is not notified by the Patient.
Duration of Storage for Personal Data
Medithrace shall store the personal data notified by the Patient for the interval that the Services are actually delivered in order to fulfill liabilities set in this Information Policy, hereby, and arise out of the content of Services to help the Patient use the Services.
Our Measures and Commitments for Data Security
Pursuant to provisions set by relevant legislation or mentioned in this Information Policy, Medithrace commits to take necessary technical and administrative measures to ensure appropriate level of security in order to prevent illegal access to the personal data and/or illegal data processing.
Possible Changes in Information Policy
Medithrace shall be entitled to amend provisions of this Information Policy at any time, provided the amended policy is accessible at the Web Site, www.medithrace.com. The amendments made in the Information Policy by Medithrace shall be put into force immediately after the amended provisions are publicized.
By signing the declaration and consent document, I agree and state that I received the information and consent document, I read and understood the content and my personal data is processed, used and disclosed to third parties if necessary for my potential treatment.